Work

Impact of genomic aberrations and additional therapies on survival outcomes of patients with operable non-small cell lung cancer (NSCLC) from the NEOSTAR study.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.15_suppl.8542

Authors: Nicolas Zhou, Boris Sepesi, Cheuk Hong Leung, Heather Y. Lin, William Nassib William, Annikka Weissferdt, Apar Pataer, Myrna Godoy, Frank V. Fossella, George Blumenschein, Xiuning Le, Anne S. Tsao, Jianjun Zhang, Wayne L. Hofstetter, Stephen Swisher, Ara A. Vaporciyan, J. Jack Lee, Don Lynn Gibbons, John Heymach, Tina Cascone

Institutions: The University of Texas MD Anderson Cancer Center, Beneficência Portuguesa de São Paulo

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Conquer Cancer Foundation, National Institutes of Health

OpenAlex ID: W3169599727

Cites:

Cited by: 3

Related to: 10